Table of Contents Author Guidelines Submit a Manuscript
International Journal of Surgical Oncology
Volume 2012, Article ID 723916, 8 pages
http://dx.doi.org/10.1155/2012/723916
Review Article

Memorial Sloan-Kettering Cancer Center: Two Decades of Experience with Ductal Carcinoma In Situ of the Breast

Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 300 East 66th Street, 8th Floor, New York, NY 10065, USA

Received 20 January 2012; Accepted 13 February 2012

Academic Editor: Virgilio Sacchini

Copyright © 2012 Daniel Xavier Choi and Kimberly J. Van Zee. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. L. Ernster, J. Barclay, K. Kerlikowske, D. Grady, and I. C. Henderson, “Incidence of and treatment for ductal carcinoma in situ of the breast,” Journal of the American Medical Association, vol. 275, no. 12, pp. 913–918, 1996. View at Publisher · View at Google Scholar · View at Scopus
  2. P. C. Stomper and F. R. Margolin, “Ductal carcinoma in situ: the mammographer's perspective,” American Journal of Roentgenology, vol. 162, no. 3, pp. 585–591, 1994. View at Google Scholar · View at Scopus
  3. S. L. Parker, T. Tong, S. Bolden, and P. A. Wingo, “Cancer statistics, 1996,” Ca-A Cancer Journal for Clinicians, vol. 46, no. 1, pp. 5–27, 1996. View at Google Scholar · View at Scopus
  4. D. D. Dershaw, A. Abramson, and D. W. Kinne, “Ductal carcinoma in situ: mammographic findings and clinical implications,” Radiology, vol. 170, no. 2, pp. 411–415, 1989. View at Google Scholar · View at Scopus
  5. B. Fisher, M. Bauer, and R. Margolese, “Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer,” The New England Journal of Medicine, vol. 312, no. 11, pp. 665–673, 1985. View at Google Scholar
  6. U. Veronesi, R. Saccozzi, and M. Del Vecchio, “Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast,” The New England Journal of Medicine, vol. 305, no. 1, pp. 6–11, 1981. View at Google Scholar
  7. L. Liberman, K. J. Van Zee, D. D. Dershaw, E. A. Morris, A. F. Abramson, and B. Samli, “Mammographic features of local recurrence in women who have undergone breast-conserving therapy for ductal carcinoma in situ,” American Journal of Roentgenology, vol. 168, no. 2, pp. 489–493, 1997. View at Google Scholar · View at Scopus
  8. H. S. Cody, N. Klauber-DeMore, P. I. Borgen, and K. J. Van Zee, “Is it really duct carcinoma in situ?” Annals of Surgical Oncology, vol. 8, no. 8, pp. 617–619, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. H. S. Cody and K. J. Van Zee, “Point: sentinel lymph node biopsy is indicated for patients with DCIS,” Journal of the National Comprehensive Cancer Network, vol. 1, no. 2, pp. 199–206, 2003. View at Google Scholar · View at Scopus
  10. M. D. Lagios and M. J. Silverstein, “Sentinel node biopsy for patients with DCIS: a dangerous and unwarranted direction,” Annals of Surgical Oncology, vol. 8, no. 4, pp. 275–277, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. S. A. McLaughlin, M. J. Wright, K. T. Morris et al., “Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors,” Journal of Clinical Oncology, vol. 26, no. 32, pp. 5220–5226, 2008. View at Publisher · View at Google Scholar
  12. S. A. McLaughlin, M. J. Wright, K. T. Morris et al., “Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements,” Journal of Clinical Oncology, vol. 26, no. 32, pp. 5213–5219, 2008. View at Publisher · View at Google Scholar
  13. N. Klauber-DeMore, L. K. Tan, L. Liberman et al., “Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?” Annals of Surgical Oncology, vol. 7, no. 9, pp. 636–642, 2000. View at Google Scholar · View at Scopus
  14. K. H. Moore, K. J. Sweeney, M. E. Wilson et al., “Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit,” Annals of Surgical Oncology, vol. 14, no. 10, pp. 2911–2917, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. A. C. Ascensao, M. S. J. Marques, and M. Capitao-Mor, “Paget's disease of the nipple: clinical and pathological review of 109 female patients,” Dermatologica, vol. 170, no. 4, pp. 170–179, 1985. View at Google Scholar · View at Scopus
  16. J. H. Yim, M. R. Wick, G. W. Philpott, J. A. Norton, and G. M. Doherty, “Underlying pathology in mammary Paget's disease,” Annals of Surgical Oncology, vol. 4, no. 4, pp. 287–292, 1997. View at Google Scholar · View at Scopus
  17. M. Morrogh, E. A. Morris, L. Liberman, K. Van Zee, H. S. Cody, and T. A. King, “MRI identifies otherwise occult disease in select patients with Paget disease of the nipple,” Journal of the American College of Surgeons, vol. 206, no. 2, pp. 316–321, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. K. J. Van Zee, L. Liberman, B. Samli et al., “Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: the effect of age,” Cancer, vol. 86, no. 9, pp. 1757–1767, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. U. Veronesi, A. Luini, M. Del Vecchio et al., “Radiotherapy after breast-preserving surgery in women with localized cancer of the breast,” The New England Journal of Medicine, vol. 328, no. 22, pp. 1587–1591, 1993. View at Publisher · View at Google Scholar · View at Scopus
  20. E. S. Hwang, B. Samli, K. N. Tran, P. P. Rosen, P. I. Borgen, and K. J. Van Zee, “Volume of resection in patients treated with breast conservation for ductal carcinoma in situ,” Annals of Surgical Oncology, vol. 5, no. 8, pp. 757–763, 1998. View at Google Scholar · View at Scopus
  21. A. Recht, J. L. Connolly, S. J. Schnitt et al., “The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy,” International Journal of Radiation Oncology Biology Physics, vol. 14, no. 1, pp. 3–10, 1988. View at Google Scholar · View at Scopus
  22. J. M. Kurtz, J. Jacquemier, R. Amalric et al., “Why are local recurrences after breast-conserving therapy more frequent in younger patients?” Journal of Clinical Oncology, vol. 8, no. 4, pp. 591–598, 1990. View at Google Scholar
  23. A. J. Nixon, D. Neuberg, D. F. Hayes et al., “Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer,” Journal of Clinical Oncology, vol. 12, no. 5, pp. 888–894, 1994. View at Google Scholar
  24. A. Ho, A. Goenka, N. Ishill et al., “The effect of age in the outcome and treatment of older women with ductal carcinoma in situ,” Breast, vol. 20, no. 1, pp. 71–77, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. B. D. Smith, G. L. Smith, A. Hurria, G. N. Hortobagyi, and T. A. Buchholz, “Future of cancer incidence in the United States: burdens upon an aging, changing nation,” Journal of Clinical Oncology, vol. 27, no. 17, pp. 2758–2765, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Fisher, S. Land, E. Mamounas, J. Dignam, E. R. Fisher, and N. Wolmark, “Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience,” Seminars in Oncology, vol. 28, no. 4, pp. 400–418, 2001. View at Google Scholar · View at Scopus
  27. J. Houghton, “Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial,” The Lancet, vol. 362, no. 9378, pp. 95–102, 2003. View at Publisher · View at Google Scholar
  28. J. Cuzick, I. Sestak, S. E. Pinder et al., “Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial,” The Lancet Oncology, vol. 12, no. 1, pp. 21–29, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Correa, P. McGale, C. Taylor et al., “Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast,” Journal of the National Cancer Institute—Monographs, vol. 2010, no. 41, pp. 162–177, 2010. View at Publisher · View at Google Scholar
  30. U. Rudloff, E. Brogi, J. P. Brockway et al., “Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapy,” Cancer, vol. 115, no. 6, pp. 1203–1214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. M. J. Silverstein, “The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast,” American Journal of Surgery, vol. 186, no. 4, pp. 337–343, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. M. J. Silverstein, M. D. Lagios, S. Groshen et al., “The influence of margin width on local control of ductal carcinoma in situ of the breast,” The New England Journal of Medicine, vol. 340, no. 19, pp. 1455–1461, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. U. Rudloff, E. Brogi, A. S. Reiner et al., “The influence of margin width and volume of disease near margin on benefit of radiation therapy for women with DCIS treated with breast-conserving therapy,” Annals of Surgery, vol. 251, no. 4, pp. 583–591, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. N. Bijker, P. Meijnen, J. L. Peterse et al., “Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of european organisation for research and treatment of cancer randomized phase III trial 10853—a study by the EORTC breast cancer cooperative group and EORTC radiotherapy group,” Journal of Clinical Oncology, vol. 24, no. 21, pp. 3381–3387, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Hughes, M. Wang, D. Page et al., “Five year results of intergroup study E5194: local excision alone (without radiation treatment) for selected patients with ductal carcinoma in situ (DCIS),” Breast Cancer Research and Treatment, vol. 100, supplement 1, p. S15, 2006. View at Publisher · View at Google Scholar
  36. J. S. Wong, C. M. Kaelin, S. L. Troyan et al., “Prospective study of wide excision alone for ductal carcinoma in situ of the breast,” Journal of Clinical Oncology, vol. 24, no. 7, pp. 1031–1036, 2006. View at Publisher · View at Google Scholar
  37. I. L. Wapnir, J. J. Dignam, B. Fisher et al., “Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS,” Journal of the National Cancer Institute, vol. 103, no. 6, pp. 478–488, 2011. View at Publisher · View at Google Scholar
  38. L. Holmberg, H. Garmo, B. Granstrand et al., “Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast,” Journal of Clinical Oncology, vol. 26, no. 8, pp. 1247–1252, 2008. View at Publisher · View at Google Scholar
  39. E. Ceilley, R. Jagsi, S. Goldberg, L. Kachnic, S. Powell, and A. Taghian, “The management of ductal carcinoma in situ in North America and Europe: results of a survey,” Cancer, vol. 101, no. 9, pp. 1958–1967, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. T. W. F. Yen, H. M. Kuerer, R. A. Ottesen et al., “Impact of randomized clinical trial results in the National Comprehensive Cancer Network on the use of tamoxifen after breast surgery for ductal carcinoma in situ,” Journal of Clinical Oncology, vol. 25, no. 22, pp. 3251–3258, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. U. Rudloff, L. M. Jacks, J. I. Goldberg et al., “Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ,” Journal of Clinical Oncology, vol. 28, no. 23, pp. 3762–3769, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. L. C. Collins, N. Achacoso, Z. Sharafali et al., “Predictors of local recurrence (LR) in patients with ductal carcinoma in situ (DCIS) treated by breast conserving therapy (BCT): Value of the Memorial Sloan-Kettering (MSK) nomogram,” in Proceedings of the 101st Annual Meeting of the United States and Canadian Academy of Pathology, March 2012.
  43. M. Yi, F. Meric-Bernstam, H. M. Kuerer et al., “Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision,” Journal of Clinical Oncology, vol. 30, no. 6, pp. 600–607, 2012. View at Google Scholar